1. The Therapeutic Role of Cannabinoid Receptors and Its Agonists or Antagonists in Parkinson's Disease. Han QW#, Yuan YH*, Chen NH*. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109745.
2. CZ-7, a New Derivative of Claulansine F, Promotes Remyelination Induced by Cuprizone by Enhancing Myelin Debris Clearance. Wang SS#, Bi HZ, Chu SF, Dong YX, He WB, Tian YJ, Zang YD, Zhang DM, Zhang Z*, Chen NH*. Brain Res Bull. 2020 Apr 11;159:67-78.
3. Potential Application of Endocannabinoid System Agents in Neuropsychiatric and Neurodegenerative Diseases-Focusing on FAAH/MAGL Inhibitors. Ren SY#, Wang ZZ, Zhang Y, Chen NH*. Acta Pharmacol Sin. 2020 Oct;41(10):1263-1271.
4. Donepezil Attenuates Vascular Dementia in Rats Through Increasing BDNF Induced by Reducing HDAC6 Nuclear Translocation. Jian WX#, Zhang Z, Zhan JH, Chu SF, Peng Y, Zhao M, Wang Q, Chen NH*. Acta Pharmacol Sin. 2020 May;41(5):588-598.
5. Anti-inflammatory effects of higenamine (Hig) on LPS-activated mouse microglia (BV2) through NF-κB and Nrf2/HO-1 signaling pathways. Yang SW#, Chu SF, Ai QD, Zhang Z, Gao Y, Lin MY, Liu YJ, Hu YM, Li X, Peng Y, Pan YW, He QH, Chen NH*. Int Immunopharmacol. 2020 Aug;85:106629.
6. Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-synuclein in BV-2 cells. Shao QH#, Yan WF#, Zhang Z, Ma KL, Peng SY, Cao YL, Yuan YH*, Chen NH*. Neuropharmacology. 2019 Jan;144:388-399.
7. Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway. Chu SF#, Zhang Z, Zhou X, He WB, Chen C, Luo P, Liu DD, Ai QD, Gong HF, Wang ZZ, Sun HS, Feng ZP, Chen NH*. Acta Pharmacol Sin. 2019 Jan;40(1):13-25.
8. IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization. Chen C#, Ai QD, Chu SF, Zhang Z, Zhou X, Luo P, Liu YJ, Chen NH*. Int Immunopharmacol. 2019 Feb 20;70:69-79.
9. RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells. Zhang XL#, Wang ZZ, Shao QH, Zhang Z, Li L, Guo ZY, Sun HM, Zhang Y*, Chen NH*. Brain Res Bull. 2019 Mar;146:228-236.
10. The effects of glucocorticoids on depressive and anxiety-like behaviors, mineralocorticoid receptor-dependent cell proliferation regulates anxiety-like behaviors. Chen J#, Wang ZZ, Zhang S, Chu SF, Mou Z, Chen NH*. Behav Brain Res. 2019 Apr 19;362:288-298.
11. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease. Wang S#, Yuan YH*, Chen NH*, Wang HB. Int Immunopharmacol. 2019 Feb;67:458-464.
12. CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses. Liu DD#, Yuan X#, Chu SF, Chen C, Ren Q, Luo P, Lin MY, Wang SS, Zhu TB, Ai QD, Zang YD, Zhang DM, He X, Huang ZH, Sun HS, Feng ZP, Chen NH*. Acta Pharmacol Sin. 2019 Apr;40(4):425-440.
13. IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats. Ai QD#, Chen C, Chu SF, Luo Y, Zhang Z, Zhang S, Yang PF, Gao Y, Zhang XL, Chen NH*. Int. J. Mol. Sci. 2019, 20, 1661.
14. A20 as a novel target for the anti-neuroinflammatory effect of chrysin via inhibition of NF-κB signaling pathway. Li ZP#*, Chu SF#, He WB, Zhang Z, Liu JQ, Cui LY, Yan X, Li DF*, Chen NH*. Brain Behav Immun. 2019 Jul; 79:228-235.
15. CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4. Chen C#, Chu SF, Ai QD, Zhang Z, Guan FF, Wang SS, Dong YX, Zhu J, Jian WX, Chen NH*. Cell Mol Neurobiol. 2019 Jul;39(5):651-669.
16. NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP. Chen Y#, Zhang QS, Shao QH, Wang S, Yuan YH*, Chen NH*, Wang HB. Acta Pharmacol Sin. 2019 Aug;40(8):991-998.
17. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation. Ai QD#, Chen C, Chu SF, Zhang Z, Luo Y, Guan FF, Lin MY, Liu DD, Wang SS, Chen NH*. Transl Res. 2019 Oct;212:36-53.
18. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease. Shao QH#, Chen Y, Li FF, Wang S, Zhang XL, Yuan YH*, Chen NH*. Acta Pharmacol Sin. 2019 Dec;40(12):1503-1512.
19. Chemokines play complex roles in cerebral ischemia. Chen C#, Chu SF, Liu DD, Zhang Z, Kong LL, Zhou X, Chen NH*. Neurochem Int. 2018 Jan;112:146-158.
20. Gap junction channels as potential targets for the treatment of major depressive disorder. Ren Q#, Wang ZZ, Chu SF, Xia CY, Chen NH*. Psychopharmacology (Berl). 2018 Jan;235(1):1-12.
21. RTP801 is a critical factor in the neurodegeneration process of A53T alpha-synuclein in a mouse model of Parkinson's disease under chronic restraint stress. Zhang Z#, Chu SF#, Wang SS, Jiang YN, Gao Y, Yang PF, Ai QD, Chen NH*. Br J Pharmacol. 2018 Feb;175(4):590-605.
22. NLRP3 inflammasome activation in the thymus of MPTP-induced Parkinsonian mouse model. Wen L#, Zhang QS, Heng Y, Chen Y, Wang S, Yuan YH*, Chen NH*. Toxicol Lett. 2018 May 15;288:1-8.
23. A novel mechanism of depression: role for connexins. Xia CY#, Wang ZZ, Yamakuni T, Chen NH*. Eur Neuropsychopharmacol. 2018 Apr;28(4):483-498.
24. Anti-neuroinflammatory effects of 20C from Gastrodia elata via regulating autophagy in LPS-activated BV-2 cells through MAPKs and TLR4/Akt/mTOR signaling pathways. Shao QH#, Zhang XL, Chen Y, Zhu CG, Shi JG, Yuan YH*, Chen NH*. Mol Immunol. 2018 Jul;99:115-123.
25. Prion-like propagation of α-synuclein in the gut-brain axis. Chen Y#, Shao QH, Yuan YH*, Chen NH*. Brain Res Bull. 2018 Jun;140:341-346.
26. Glucocorticoid receptor activation induces decrease of hippocampal astrocyte number in rats. Lou YX#, Li J, Wang ZZ, Xia CY, Chen NH*. Psychopharmacology (Berl). 2018 Sep;235(9):2529-2540.
27. Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-α expression. Wan JF#, Chu SF, Zhou X, Li YT, He WB, Tan F, Luo P, Ai QD, Wang Q, Chen NH*. Acta Pharmacol Sin. 2018 Sep;39(9):1493-1500.
28. The extended application of the rat brain in stereotaxic coordinates in rats of various body weight. Yang PF#, Wang ZZ#, Zhang Z, Liu DD, Manolios EN, Chen C, Yan X, Zuo W, Chen NH*. J Neurosci Methods. 2018 Sep 1;307:60-69.
29. IMM-H004, a Novel Coumarin Derivative Compound, Inhibits H2O2-Induced Neurotoxicity via Antioxidant and Antiapoptosis in PC12 Cells. Song XY#, Hu JF, Wu DH, Ji HJ, Chen NH*. J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3396-3403.
30. Corticosterone impairs gap junctions in the prefrontal cortical and hippocampal astrocytes via different mechanisms. Xia CY#, Wang ZZ, Zhang Zhao, Chen J, Wang YY, Lou YX, Gao Y, Luo P, Ren Q, Du GH, Chen NH*. Neuropharmacology. 2018 Mar 15;131:20-30.
31. Progress in Pharmacological Research of chemokine like factor 1 (CKLF1). Liu DD#, Song XY, Yang PF, Ai QD, Wang YY, Feng XY, He Xin, Chen NH*. Cytokine. 2018 Feb;102:41-50.
32. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Zhang QS#, Heng Y, Mou Z, Huang JY, Yuan YH*, Chen NH*. Acta Pharmacol Sin. 2017 Oct;38(10):1317-1328.